Malek Chamoun
Fortuna: 47 $ al 31/05/2026
Fortuna: 47 $ al 31/05/2026
Malek Chamoun is the founder.
He founded Nora Pharma, Inc. in 2017 and currently holds the title of President.
Mr. Chamoun also worked as the Chief Development Officer at Sunshine Biopharma, Inc. Mr. Chamoun completed his undergraduate degree at Hautes Etudes Commerciales in 2008.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/05/2026 | 185 ( 0 % ) | 47 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Sells generic drugs | Fundador | 01/01/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Hautes Etudes Commerciales
Hautes Etudes Commerciales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of cancer | Health Technology |
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Sells generic drugs | Distribution Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.